Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.91.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.14 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.4.14 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.359EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.359EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.15.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.15.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.20EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.7.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.9.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.9.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FA.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
FA.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ER.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
ER.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.11EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.4.1.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.35EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.1.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.2.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
XAY.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CH.1.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BE.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.7.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.34EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.4.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CH.1.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.7.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BZ.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BZ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CK.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.13EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CM.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used